Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
10
SSKN Quote, Financials, Valuation and Earnings
Last price:
$0.26
Seasonality move
:
-3.35%
Day range:
$0.23 - $0.27
52-week range:
$0.12 - $3.86
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
1.01x
Volume:
52.4K
Avg. volume:
849.3K
1-year change:
-91.48%
Market cap:
$1.3M
Revenue:
$33.6M
EPS (TTM):
-$2.62
Analysts' Opinion
-
Consensus RatingSTRATA Skin Sciences, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $7.40, STRATA Skin Sciences, Inc. has an estimated upside of 4700% from its current price of $0.23.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $0.23.
Fair Value
-
According to the consensus of 1 analyst, STRATA Skin Sciences, Inc. has 4700% upside to fair value with a price target of $7.40 per share.
SSKN vs. S&P 500
-
Over the past 5 trading days, STRATA Skin Sciences, Inc. has underperformed the S&P 500 by -8.79% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
STRATA Skin Sciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
STRATA Skin Sciences, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter STRATA Skin Sciences, Inc. reported revenues of $6.9M.
Earnings Growth
-
STRATA Skin Sciences, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter STRATA Skin Sciences, Inc. reported earnings per share of -$0.36.
Enterprise value:
10.6M
EV / Invested capital:
--
Price / LTM sales:
0.03x
EV / EBIT:
--
EV / Revenue:
0.34x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
-3.01x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$17.9M
Return On Assets:
-31.94%
Net Income Margin (TTM):
-35.64%
Return On Equity:
-296.68%
Return On Invested Capital:
-54.88%
Operating Margin:
-26.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $35.3M | $32.7M | $31M | $8.8M | $6.9M | |
| Gross Profit | $20.5M | $18.1M | $17.9M | $5.3M | $4.2M | |
| Operating Income | -$5M | -$6.1M | -$6.5M | -$1.6M | -$1.9M | |
| EBITDA | $971K | -$754K | -$1.6M | -$285K | -$906K | |
| Diluted EPS | -$2.06 | -$2.59 | -$2.62 | -$0.51 | -$0.36 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $20M | $18.8M | $19.7M | $15.9M | $14.3M | |
| Total Assets | $46.8M | $53.2M | $47.2M | $40.2M | $30.7M | |
| Current Liabilities | $12.2M | $14.2M | $12M | $14M | $15M | |
| Total Liabilities | $20.6M | $31.4M | $31M | $30.9M | $29.4M | |
| Total Equity | $26.2M | $21.8M | $16.2M | $9.3M | $1.3M | |
| Total Debt | $7.7M | $8.1M | $15.3M | $16.2M | $16M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2M | $991K | -$1.9M | -$302K | -$64K | |
| Cash From Investing | -$4.7M | -$1.9M | -$1.7M | $1.1M | -$1M | |
| Cash From Financing | $6.4M | $1.9M | $2.2M | $1.9M | $2.2M | |
| Free Cash Flow | -$6.7M | -$2M | -$3.5M | -$364K | -$1.1M | |
SSKN
Sector
Market Cap
$1.3M
$25.6M
Price % of 52-Week High
5.83%
50%
Dividend Yield
0%
0%
Shareholder Yield
-19.83%
-1.62%
1-Year Price Total Return
-91.48%
-18.97%
Beta (5-Year)
0.448
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.23
200-day SMA
Sell
Level
$1.72
Bollinger Bands (100)
Sell
Level
0.86 - 1.76
Chaikin Money Flow
Sell
Level
-2.9M
20-day SMA
Sell
Level
$0.62
Relative Strength Index (RSI14)
Sell
Level
23.91
ADX Line
Sell
Level
14.28
Williams %R
Buy
Level
-90.7957
50-day SMA
Sell
Level
$1.01
MACD (12, 26)
Buy
Level
0.07
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Sell
Level
-3.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-8.685)
Sell
CA Score
(Annual)
Level (-2.016)
Buy
Beneish M-Score
(Annual)
Level (-3.8253)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (5.1262)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The company was founded by Dina Gutkowicz-Krusin in December 1989 and is headquartered in Horsham, PA.
Stock Forecast FAQ
In the current month, SSKN has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SSKN average analyst price target in the past 3 months is $7.40.
-
Where Will STRATA Skin Sciences, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that STRATA Skin Sciences, Inc. share price will rise to $7.40 per share over the next 12 months.
-
What Do Analysts Say About STRATA Skin Sciences, Inc.?
Analysts are divided on their view about STRATA Skin Sciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that STRATA Skin Sciences, Inc. is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is STRATA Skin Sciences, Inc.'s Price Target?
The price target for STRATA Skin Sciences, Inc. over the next 1-year time period is forecast to be $7.40 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SSKN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for STRATA Skin Sciences, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SSKN?
You can purchase shares of STRATA Skin Sciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase STRATA Skin Sciences, Inc. shares.
-
What Is The STRATA Skin Sciences, Inc. Share Price Today?
STRATA Skin Sciences, Inc. was last trading at $0.26 per share. This represents the most recent stock quote for STRATA Skin Sciences, Inc.. Yesterday, STRATA Skin Sciences, Inc. closed at $0.23 per share.
-
How To Buy STRATA Skin Sciences, Inc. Stock Online?
In order to purchase STRATA Skin Sciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SSKN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SSKN
Sector
P/E ratio
--
23.22x
PEG ratio
-0.07x
-0.01x
P/B ratio
1.01x
1.80x
Price / LTM sales
0.03x
1.53x
Growth Metrics
SSKN
Sector
Revenue growth
-21.24%
3.44%
Earnings growth
29.5%
11.15%
Revenue (5-year growth)
1.22%
6.46%
Earnings forecast
-$0.26
-$0.19
Profitability
SSKN
Sector
Profitability FY 2024
$19.1M
$2.4M
Return on invested capital
-54.88%
-33.43%
Return on assets
-31.94%
-29.79%
Return on equity
-296.68%
-39.31%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
25
Estimated Next Earnings Date
Feb
12
Balance Sheet
SSKN
Sector
Total cash
$7.1M
$24.1M
Short term investments
--
$23.8M
Total assets
$36.9M
$70.2M
Long term debt
$16M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
50
AXTI alert for Mar 3
AXT, Inc. [AXTI] is down 9.65% over the past day.
Buy
53
AAOI alert for Mar 3
Applied Optoelectronics, Inc. [AAOI] is down 6.93% over the past day.
Sell
32
TPB alert for Mar 3
Turning Point Brands, Inc. [TPB] is down 0.87% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
